Amphotericin B Dose Optimization in Children with Malignant Diseases

Publisher： Karger

E-ISSN： 1421-9794|53|2|142-147

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.2, 2007-02, pp. : 142-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Dose Amphotericin B Lipid Complex for the Treatment of Persistent Fever of Unknown Origin in Patients with Hematologic Malignancies and Prolonged Neutropenia

By  

Chemotherapy, Vol. 45, Iss. 3, 1999-04 ,pp. : 205-212

Karger

Access to resources Recommend Favorite

Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 15-26

Karger

Access to resources Recommend Favorite

Pediatric Palliative Care for Children with Progressive Non-Malignant Diseases

By Siden Harold  

Children, Vol. 5, Iss. 2, 2018-02 ,pp. : 28-28

MDPI

Access to resources Recommend Favorite

Safety and Efficacy of Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 67-76

Karger

Access to resources Recommend Favorite

Synergism of CAY-1 with Amphotericin B and Itraconazole

By  

Chemotherapy, Vol. 52, Iss. 6, 2006-10 ,pp. : 285-287

Karger

Access to resources Recommend Favorite